Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGEM
4201
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $417K | ﹤0.01% |
23,118
+22,477
| +3,507% | +$362K |
|
4202
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $416K | ﹤0.01% |
9,600
-5,400
| -36% | -$224K |
|
|
JNS
4203
DELISTED
Janus Capital Group Inc
JNS
| $416K | ﹤0.01% |
34,613
-14,384
| -29% | -$148K |
|
4204
BlackRock Floating Rate Income Trust
BGT
$325M
| $415K | ﹤0.01% |
31,936
+1,818
| +6% | +$25.5K |
|
|
NILE
4205
CALL
DELISTED
Blue Nile, Inc.
NILE
| $414K | ﹤0.01% |
8,800
-600
| -6% | -$26K |
|
|
EXAS
4206
DELISTED
Exact Sciences
EXAS
| $413K | ﹤0.01% |
37,530
+25,058
| +201% | +$287K |
|
|
EXAS
4207
PUT
DELISTED
Exact Sciences
EXAS
| $413K | ﹤0.01% |
37,500
+15,300
| +69% | +$176K |
|
|
DMND
4208
DELISTED
DIAMOND FOODS, INC.
DMND
| $413K | ﹤0.01% |
16,512
-36,533
| -69% | -$873K |
|
|
MYC
4209
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
| $412K | ﹤0.01% |
31,703
+14,771
| +87% | +$207K |
|
4210
CALL
Blackrock
BLK
$176B
| $411K | ﹤0.01% |
1,300
-12,400
| -91% | -$3.7M |
|
4211
FerroAtlántica
GSM
$839M
| $411K | ﹤0.01% |
22,847
-22,950
| -50% | -$395K |
|
|
GTI
4212
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
| $411K | ﹤0.01% |
37,379
+7,795
| +26% | +$79.6K |
|
|
DCH
4213
Dauch Corp
DCH
$1.51B
| $410K | ﹤0.01% |
20,495
-47,111
| -70% | -$900K |
|
4214
PUT
Edgewell Personal Care
EPC
$1.31B
| $410K | ﹤0.01% |
5,126
-2,159
| -30% | -$164K |
|
4215
CALL
Manulife Financial
MFC
$73.5B
| $410K | ﹤0.01% |
21,600
+700
| +3% | +$12.8K |
|
4216
CALL
Robert Half
RHI
$4.37B
| $410K | ﹤0.01% |
10,000
+8,500
| +567% | +$335K |
|
|
SFLY
4217
PUT
DELISTED
Shutterfly, Inc.
SFLY
| $410K | ﹤0.01% |
8,200
-3,700
| -31% | -$187K |
|
|
CLC
4218
CALL
DELISTED
Clarcor
CLC
| $410K | ﹤0.01% |
6,400
+6,200
| +3,100% | +$368K |
|
4219
Acadia Healthcare
ACHC
$2.94B
| $409K | ﹤0.01% |
8,689
+7,015
| +419% | +$305K |
|
4220
CALL
Alkermes
ALKS
$8.25B
| $408K | ﹤0.01% |
+10,200
| New | +$377K |
|
4221
CALL
iShares MSCI Australia ETF
EWA
$1.45B
| $408K | ﹤0.01% |
17,000
+3,900
| +30% | +$99.7K |
|
4222
CALL
Lithia Motors
LAD
$8.26B
| $407K | ﹤0.01% |
5,900
-2,600
| -31% | -$175K |
|
|
PDS
4223
Precision Drilling
PDS
$974M
| $407K | ﹤0.01% |
2,262
+682
| +43% | +$134K |
|
4224
Walker & Dunlop
WD
$1.53B
| $407K | ﹤0.01% |
25,336
+17,096
| +207% | +$245K |
|
4225
PUT
NETGEAR
NTGR
$635M
| $406K | ﹤0.01% |
12,700
-1,700
| -12% | -$52.9K |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.